ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Mind Medicine MindMed Inc

Mind Medicine MindMed Inc (MNMD)

7,16
0,145
(2,07%)
Geschlossen 22 Dezember 10:00PM
7,16
0,00
(0,00%)
Nach Börsenschluss: 1:22AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
7,16
Gebot
6,84
Fragen
9,00
Volumen
1.768.262
6,9225 Tagesbereich 7,355
3,35 52-Wochen-Bereich 12,22
Marktkapitalisierung
Handelsende
7,015
Handelsbeginn
6,96
Letzte Trade
3
@
7.16
Letzter Handelszeitpunkt
Finanzvolumen
US$ 12.566.340
VWAP
7,1066
Durchschnittliches Volumen (3 Mio.)
1.192.187
Ausgegebene Aktien
81.430.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,06
Gewinn pro Aktie (EPS)
-1,18
Erlöse
-
Nettogewinn
-95,73M

Über Mind Medicine MindMed Inc

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances inclu... Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Unit Inv Tr, Closed-end Mgmt
Website
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
2013
Mind Medicine MindMed Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MNMD. The last closing price for Mind Medicine MindMed was US$7,02. Over the last year, Mind Medicine MindMed shares have traded in a share price range of US$ 3,35 to US$ 12,22.

Mind Medicine MindMed currently has 81.430.000 shares in issue. The market capitalisation of Mind Medicine MindMed is US$571,23 million. Mind Medicine MindMed has a price to earnings ratio (PE ratio) of -0.06.

MNMD Neueste Nachrichten

MindMed to Be Added to the Nasdaq Biotechnology Index

Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)

- Voyage is the first-ever Phase 3 study of lysergide D-tartrate (LSD) with the primary endpoint measuring the change from baseline in the Hamilton Anxiety Rating Scale (HAM-A) score at week 12...

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

- Innovation Passport Designation Aims to Accelerate Time to Market and Facilitate Patient Access to Innovative Medicines - Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or...

MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

MindMed Announces New Employee Inducement Grants

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

MindMed to Participate in Upcoming Investor Conferences

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.131.849217638697.038.1156.8713070787.2349713CS
4-0.005-0.06978367062117.1658.5556.8711389987.49788052CS
121.220.13422818795.969.855.032911921877.28981668CS
26-0.16-2.185792349737.329.855.032910869577.18054335CS
523.59100.560224093.5712.223.3513630077.86680343CS
156-18.19-71.755424063125.3525.652.12211227011.73329316CS
260-79.39-91.727325245586.5586.552.12286381926.15722795CS

MNMD - Frequently Asked Questions (FAQ)

What is the current Mind Medicine MindMed share price?
The current share price of Mind Medicine MindMed is US$ 7,16
How many Mind Medicine MindMed shares are in issue?
Mind Medicine MindMed has 81.430.000 shares in issue
What is the market cap of Mind Medicine MindMed?
The market capitalisation of Mind Medicine MindMed is USD 571,23M
What is the 1 year trading range for Mind Medicine MindMed share price?
Mind Medicine MindMed has traded in the range of US$ 3,35 to US$ 12,22 during the past year
What is the PE ratio of Mind Medicine MindMed?
The price to earnings ratio of Mind Medicine MindMed is -0,06
What is the reporting currency for Mind Medicine MindMed?
Mind Medicine MindMed reports financial results in USD
What is the latest annual profit for Mind Medicine MindMed?
The latest annual profit of Mind Medicine MindMed is USD -95,73M
What is the registered address of Mind Medicine MindMed?
The registered address for Mind Medicine MindMed is 101-1220 W 6TH AVENUE, VANCOUVER, BRITISH COLUMBIA, V6H 1A5
What is the Mind Medicine MindMed website address?
The website address for Mind Medicine MindMed is www.mindmed.com
Which industry sector does Mind Medicine MindMed operate in?
Mind Medicine MindMed operates in the UNIT INV TR, CLOSED-END MGMT sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock